Imperial College London

Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and operated by Meta Analytics LLC.  According to the platform’s definition, Highly...

The journal Nature published a new research analysis from Imperial College London (ICL)’s Center for Psychedelic Research and University of California San Francisco (UCSF)’s Psychedelics Division, including renowned David Erritzoe and Robin Carhart-Harris. The study...

Recent peer-reviewed research published in the journal Nature posits that a small dose of MDMA could be helpful against uncomfortable or difficult experiences and amplify positive ones when combined with either psilocybin or LSD. The study, published in August and authored...

Starting this October, scientists at Imperial College London’s (ICL) Centre for Psychedelic Research will assess psilocybin-assisted therapy for gambling addiction, noted Psychedelic Spotlight.  Government-funded, the study will focus on understanding brain function in the gambling...

Fintech FluidAI, a fintech platform operating in the tokenized market, announced Monday it has teamed up with I-X, the artificial intelligence initiative of Imperial College London. This partnership is the first globally recognized university AI collaboration to be partially financed...

Jamaica and Netherlands-based wellbeing company Beckley Retreats is furthering its commitment to veteran suicide prevention through a renewed strategic partnership with the Heroic Hearts Project and Imperial College London (ICL) to continue research on the benefits of psychedelic-assisted therapies...

The research renaissance into the neuroscience and therapeutic applications of psychedelics represents one of the most promising initiatives in brain science and neuropsychopharmacology, given the huge unmet needs in the therapeutic areas they aim to treat. Actually, the fundamental...